Vijaya Diagnostic CentreBOM:543350 -1.17%81 ROA % is 12.72% as of Mar. 2026, which is 1% below its 10-year median of 12.85. GuruFocus rates BOM:543350 with a GF Score™ of 81/100 and a GF Value™ of ₹1,184.66 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Vijaya Diagnostic Centre ranks better than 89.3% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Vijaya Diagnostic Centre's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹1,917 Mil.
Vijaya Diagnostic Centre's average Total Assets over the quarter that ended in Mar. 2026 was ₹15,070 Mil. Therefore, Vijaya Diagnostic Centre's annualized ROA % for the quarter that ended in Mar. 2026 was 12.72%.
The historical rank and industry rank for Vijaya Diagnostic Centre's ROA % or its related term are showing as below:
BOM:543350'
s ROA % Range Over the Past 10 Years
Min: 10.8 Med: 12.85 Max: 17.48
Current: 12.42
During the past 8 years, Vijaya Diagnostic Centre's highest ROA % was 17.48%. The lowest was 10.80%. And the median was 12.85%.
BOM:543350's ROA % is ranked better than 89.3% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.35
vs BOM:543350: 12.42
Vijaya Diagnostic Centre (BOM:543350) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Vijaya Diagnostic Centre's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vijaya Diagnostic Centre ROA % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vijaya Diagnostic Centre's ROA % distribution charts can be found below:
* The bar in red indicates where Vijaya Diagnostic Centre's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Vijaya Diagnostic Centre (BOM:543350) has a ROA % of 12.72% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Vijaya Diagnostic Centre and its competitors. This is near median its historical median of 12.85. Over the past decade, Vijaya Diagnostic Centre's ROA % has ranged from 10.80 to 17.48. According to the industry distribution chart, Vijaya Diagnostic Centre ranks #23 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 10.7%.
Is Vijaya Diagnostic Centre's ROA % too high?
Vijaya Diagnostic Centre's current ROA % of 12.72% is near median its 10-year median of 12.85. Over the past 10 years, this metric has ranged from a low of 10.80 to a high of 17.48. Based on the distribution chart, Vijaya Diagnostic Centre ranks #23 out of 215 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Vijaya Diagnostic Centre has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vijaya Diagnostic Centre's ROA % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vijaya Diagnostic Centre ranks #23 out of 215 companies for ROA %. This places Vijaya Diagnostic Centre in the top 11% of its industry — outperforming the majority of peers. Historically, Vijaya Diagnostic Centre's own ROA % has ranged from 10.80 to 17.48 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Diagnostics & Research company?
A good ROA % depends on the Medical Diagnostics & Research industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Vijaya Diagnostic Centre and its competitors. Vijaya Diagnostic Centre's current ROA % is 12.72%, which is near median its own 10-year median of 12.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vijaya Diagnostic Centre stock overvalued right now?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre (BOM:543350) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,184.66, compared to a current price of ₹1,348.80 — trading 13.9% above its estimated fair value. The current ROA % is 12.72%, which is near median its 10-year median of 12.85. Vijaya Diagnostic Centre's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Vijaya Diagnostic Centre (BOM:543350), the current ROA % is 12.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vijaya Diagnostic Centre (BOM:543350) Overvalued in 2026?
Based on GuruFocus' analysis, Vijaya Diagnostic Centre stock appears to be overvalued.
The current stock price of ₹1,348.80 is trading 13.9% above its estimated GF Value™ of ₹1,184.66.
GuruFocus considers Vijaya Diagnostic Centre to be Modestly Overvalued.
Key valuation signals for BOM:543350:
ROA %: 12.72% (near median its 10-year median of 12.85)
GF Value™: ₹1,184.66 vs. price of ₹1,348.80 (13.9% above fair value)
No single metric tells the full story. See the BOM:543350 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vijaya Diagnostic Centre Ltd operates a diagnostic chain in Southern India. The company offers a one-stop solution for pathology and radiology testing services. It provides routine tests, specialized pathology tests, basic tests, and radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers. The company's revenue comes from many diagnostic centers, where high-volume sales drive its earnings. The Company operates within India. The company's operations fall within a single business segment, which is Diagnostic Services.
81GF Score
Get the complete analysis for BOM:543350
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543350 has been successfully added to your 
